Search

everythinglearnresearchcommunity

for

Search:↓

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

CD4+ skin cells may be precursors to basal cell carcinoma.

Leontopodium alpinum extract may help reduce hair shedding by keeping hair in the growth phase longer.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Targeting colon cancer stem cells might lead to better treatment results.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The ZIP7 gene helps control zinc levels in cells by moving zinc from the Golgi apparatus to the cytoplasm.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

FFA's causes may include environmental triggers and genetic factors.

Both mouse and rat models are effective for testing alopecia areata treatments.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.